Analysis and Characterization of Enzymes and Nucleic Acids Relevant to Toxicology

Sixth Edition: Hayes’ Principles and Methods of Toxicology

Volumn , Issue , 2014, Pages 1905-1964

  Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922284712     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b17359-52     Document Type: Chapter

References (365)

1. Guengerich, F. P. (1982) Microsomal enzymes involved in toxicology: Analysis and separation, In Principles and Methods of Toxicology (Hayes, A. W., ed.) 1st edn., pp. 609-634, Raven Press, New York.
2. Guengerich, F. P. (1989) Analysis and characterization of enzymes, In Principles and Methods of Toxicology (Hayes, A. W., ed.) 2nd edn., pp. 777-814, Raven Press, New York.
3. Guengerich, F. P. (1994) Analysis and characterization of enzymes, In Principles and Methods of Toxicology (Hayes, A. W., ed.) 3rd edn., pp. 1259-1313, Raven Press, New York.
4. Guengerich, F. P. (2001) Analysis and characterization of enzymes and nucleic acids, In Principles and Methods of Toxicology (Hayes, A. W., ed.) 4th edn., pp. 1625-1687, Taylor and Francis Group, Philadelphia, PA.
5. Guengerich, F. P. and Bartleson, C. J. (2007) Analysis and characterization of enzymes and nucleic acids, In Principles and Methods of Toxicology (Hayes, A. W., ed.) 5th edn., pp. 1981-2048, CRC Press, Boca Raton, FL.
6. Miller, E. C. and Miller, J. A. (1947) The presence and significance of bound amino azodyes in the livers of rats fed p-dimethylaminoazobenzene, Cancer Res., 7, 468-480.
7. Guengerich, F. P. (2010) Introduction and historical perspective, In Biotransformation (Guengerich, F. P., ed.), Comprehensive Toxicology, Vol. 4 (McQueen, C. A., series ed.) 2nd edn., pp. 1-7, Elsevier, Oxford, U.K.
8. Jakoby, W. B. (1980) Enzymatic Basis of Detoxication, Vols. 1 and 2, Academic Press, New York.
9. Guengerich, F. P. (1997) Introduction and historical perspective, In Biotransformation (Guengerich, F. P., ed.), Comprehensive Toxicology, Vol. 3 (Sipes, I. G., Gandolfi, J. A., and McQueen, C. A., series eds.) 1st edn., pp. 1-6, Elsevier, Oxford, U.K.
10. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A. (2004) Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development, Chem. Res. Toxicol., 17, 3-16.
11. Guengerich, F. P. (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity, Chem. Res. Toxicol., 14, 611-650.
12. Guengerich, F. P. (2005) Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation, Arch. Biochem. Biophys., 433, 369-378.
13. Liebler, D. C. and Guengerich, F. P. (2005) Elucidating mechanisms of drug-induced toxicity, Nat. Rev. Drug Discov., 4, 410-420.
14. Borzelleca, J. F. (2000) Profiles in toxicology-Paracelsus: Herald of modern toxicology, Toxicol. Sci., 53, 2-4.
15. Guengerich, F. P. (2005) Life and times in biochemical toxicology, Int. J. Toxicol., 24, 5-21.
16. Ozer, J. S., Dieterle, F., Troth, S., Perentes, E., Cordier, A., Verdes, P., Staedtler, F. et al. (2010) A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function, Nat. Biotechnol., 28, 486-494.
17. Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., Reisch, J. S. et al. (2005) Acetaminopheninduced acute liver failure: Results of a United States multicenter, prospective study, Hepatology, 42, 1364-1372.
18. Harvison, P. J., Guengerich, F. P., Rashed, M. S., and Nelson, S. D. (1988) Cytochrome P-450 isozyme selectivity in the oxidation of acetaminophen, Chem. Res. Toxicol., 1, 47-52.
19. Patten, C. J., Thomas, P. E., Guy, R. L., Lee, M., Gonzalez, F. J., Guengerich, F. P., and Yang, C. S. (1993) Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics, Chem. Res. Toxicol., 6, 511-518.
20. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973) Acetaminopheninduced hepatic necrosis. I. Role of drug metabolism, J. Pharmacol. Exp. Ther., 187, 185-194.
21. Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973) Acetaminopheninduced hepatic necrosis. II. Role of covalent binding in vivo, J. Pharmacol. Exp. Ther., 187, 195-202.
22. Streeter, A. J., Bjorge, S. M., Axworthy, D. B., Nelson, S. D., and Baillie, T. A. (1984) The microsomal metabolism and site of covalent binding to protein of 3′-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen, Drug Metab. Dispos., 12, 565-576.
23. Roberts, S. A., Price, V. F., and Jollow, D. J. (1990) Acetaminophen structure-toxicity studies: In vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide, Toxicol. Appl. Pharmacol., 105, 195-208.
24. Qiu, Y., Benet, L. Z., and Burlingame, A. L. (1998) Identification of the hepatic protein targets of reactive metabolites of acetaminophen in in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry, J. Biol. Chem., 273, 17940-17953.
25. Lee, S. S. T., Buters, J. T. M., Pineau, T., Fernandez-Salguero, P., and Gonzalez, F. J. (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen, J. Biol. Chem., 271, 12063-12067.
26. Walgren, J. L., Mitchell, M. D., and Thompson, D. C. (2005) Role of metabolism in drug-induced idiosyncratic hepatotoxicity, Crit. Rev. Toxicol., 35, 325-361.
27. Masubuchi, N., Makino, C., and Murayama, N. (2007) Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: Correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans, Chem. Res. Toxicol., 20, 455-464.
28. Obach, R. S., Kalgutkar, A. S., Soglia, J. R., and Zhao, S. X. (2008) Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose, Chem. Res. Toxicol., 21, 1814-1822.
29. Bauman, J. N., Kelly, J. M., Tripathy, S., Zhao, S. X., Lam, W. W., Kalgutkar, A. S., and Obach, R. S. (2009) Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction, Chem. Res. Toxicol., 22, 332-340.
30. Gan, J., Ruan, Q., He, B., Zhu, M., Shyu, W. C., and Humphreys, W. G. (2009) In vitro screening of 50 highly prescribed drugs for thiol adduct formation-Comparison of potential for drug-induced toxicity and extent of adduct formation, Chem. Res. Toxicol., 22, 690-698.
31. Guengerich, F. P. (2011) Metabolism-based toxicity prediction, In New Horizons in Toxicity Prediction: A Comprehensive Overview of the Current Status and Application of Predictive Toxicology (Wilson, A. E. G., ed.), pp. 542-562, Royal Society of Chemistry, Cambridge, U.K.
32. Singh, J., Petter, R. C., Baillie, T. A., and Whitty, A. (2011) The resurgence of covalent drugs, Nat. Rev. Drug Discov., 10, 307-317.
33. Cook, J. W., Hewett, C. L., and Hieger, I. (1933) The isolation of a cancer-producing hydrocarbon from coal tar. Parts I, II, and III, J. Chem. Soc., 24, 394-405.
34. Guengerich, F. P. and Johnson, W. W. (1999) Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8, 9-epoxide and relevance to toxicity and detoxication, Drug Metab. Rev., 31, 141-158.
35. Guengerich, F. P., Arneson, K. O., Williams, K. M., Deng, Z., and Harris, T. M. (2002) Reaction of aflatoxin B1 oxidation products with lysine, Chem. Res. Toxicol., 15, 780-792.
36. Johnson, W. W., Ueng, Y.-F., Yamazaki, H., Shimada, T., and Guengerich, F. P. (1997) Role of microsomal epoxide hydrolase in the hydrolysis of aflatoxin B1 8, 9-epoxide, Chem. Res. Toxicol., 10, 672-676.
37. Rendic, S. and Guengerich, F. P. (2012) Contributions of human enzymes in carcinogen metabolism, Chem. Res. Toxicol., 25, 1316-1383.
38. Penning, T. M. and Drury, J. E. (2007) Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms, Arch. Biochem. Biophys. 464, 241-250.
39. Guengerich, F. P., Kim, D.-H., and Iwasaki, M. (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects, Chem. Res. Toxicol. 4, 168-179.
40. Egner, P. A., Munoz, A., and Kensler, T. W. (2003) Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin, Mutat. Res. 523-524, 209-216.
41. Langouët, S., Coles, B., Morel, F., Becquemont, L., Beaune, P. H., Guengerich, F. P., Ketterer, B., and Guillouzo, A. (1995) Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture, Cancer Res. 55, 5574-5579.
42. Kwak, M. K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., and Kensler, T. W. (2003) Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: Identification of novel gene clusters for cell survival, J. Biol. Chem. 278, 8135-8145.
43. Guengerich, F. P. and Macdonald, T. L. (1984) Chemical mechanisms of catalysis by cytochromes P-450: A unified view, Acc. Chem. Res. 17, 9-16.
44. Ortiz de Montellano, P. R. and De Voss, J. J. (2005) Substrate oxidation by cytochrome P450 enzymes, In Cytochrome P450 Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., ed.) 3rd edn., pp. 183-245, Kluwer Academic Publishers, New York.
45. Ortiz de Montellano, P. R. and Correia, M. A. (1983) Suicidal destruction of cytochrome P-450 during oxidative drug metabolism, Annu. Rev. Pharmacol. Toxicol., 23, 481-503.
46. Correia, M. A. (2005) Inhibition of cytochrome P450enzymes, In Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., ed.), 3rd edn. pp. 247-322, Kluwer Academic Publishers, New York.
47. Wislocki, P. G., Miwa, G. T., and Lu, A. Y. H. (1980) Reactions catalyzed by the cytochrome P-450 system, In Enzymatic Basis of Detoxication, Vol. 1 (Jakoby, W. B., ed.), pp. 135-182, Academic Press, New York.
48. Guengerich, F. P. (1995) Human cytochrome P450 enzymes, In Cytochrome P450 (Ortiz de Montellano, P. R., ed.) 2nd edn., pp. 473-535, Plenum Press, New York.
49. Rendic, S. (2002) Summary of information on human CYPenzymes: Human P450 metabolism data, Drug Metab. Rev., 34, 83-448.
50. Jakoby, W. B. (1980) Detoxication enzymes, In Enzymatic Basis of Detoxication, Vol. 1 (Jakoby, W. B., ed.), pp. 1-6, Academic Press, New York.
51. Guengerich, F. P. (2005) Human cytochrome P450 enzymes, In Cytochrome P450 (Ortiz de Montellano, P. R., ed.) 3rd edn., pp. 377-530, Kluwer Academic Publishers, New York.
52. Guengerich, F. P. and Liebler, D. C. (1985) Enzymatic activation of chemicals to toxic metabolites, CRC Crit. Rev. Toxicol., 14, 259-307.
53. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R. et al. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers, and nomenclature, Pharmacogenetics, 6, 1-42.
54. Lindberg, R. L. P. and Negishi, M. (1989) Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue, Nature, 339, 632-634.
55. Distlerath, L. M. and Guengerich, F. P. (1987) Enzymology of human liver cytochromes P-450, In Mammalian Cytochromes P-450, Vol. 1 (Guengerich, F. P., ed.), pp. 133-198, CRC Press, Boca Raton, FL.
56. Guengerich, F. P. (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily members from different species, Chem. Biol. Interact., 106, 161-182.
57. Guengerich, F. P. (1984) Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals, Annu. Rev. Nutr., 4, 207-231.
58. Guengerich, F. P. (1999) Human cytochrome P-450 3A4: Regulation and role in drug metabolism, Annu. Rev. Pharmacol. Toxicol., 39, 1-17.
59. Müller-Enoch, D., Churchill, P., Fleischer, S., and Guengerich, F. P. (1984) Interaction of liver microsomal cytochrome P-450and NADPH-cytochrome P-450 reductase in the presence and absence of lipid, J. Biol. Chem., 259, 8174-8182.
60. Halvorson, M., Greenway, D., Eberhart, D., Fitzgerald, K., and Parkinson, A. (1990) Reconstitution of testosterone oxidation by purified rat cytochrome P450p (IIIA1), Arch. Biochem. Biophys., 277, 166-180.
61. Imaoka, S., Imai, Y., Shimada, T., and Funae, Y. (1992) Role of phospholipids in reconstituted cytochrome P450 3Aforms and mechanism of their activation of catalytic activity, Biochemistry, 31, 6063-6069.
62. Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., Gonzalez, F. J. et al. (1991) The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature, DNA Cell Biol., 10, 397-398.
63. Guengerich, F. P. (1987) Cytochrome P-450 enzymes and drug metabolism, In Progress in Drug Metabolism, Vol. 10 (Bridges, J. W., Chasseaud, L. F., and Gibson, G. G., eds.), pp. 1-54, Taylor and Francis Group, London, U.K.
64. Dannan, G. A., Guengerich, F. P., Kaminsky, L. S., and Aust, S. D. (1983) Regulation of cytochrome P-450. Immunochemical quantitation of eight isozymes in liver microsomes of rats treated with polybrominated biphenyl congeners, J. Biol. Chem., 258, 1282-1288.
65. Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S. (1982) Purification and characterization of liver microsomal cytochromes P-450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone, Biochemistry, 21, 6019-6030.
66. Dannan, G. A., Waxman, D. J., and Guengerich, F. P. (1986) Hormonal regulation of rat liver microsomal enzymes: Role of gonadal steroids in programming, maintenance, and suppression of Δ4-steroid 5α-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450, J. Biol. Chem., 261, 10728-10735.
67. Waxman, D. J., Dannan, G. A., and Guengerich, F. P. (1985) Regulation of rat hepatic cytochrome P-450: Age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes, Biochemistry, 24, 4409-4417.
68. Williams, S. S., Dunham, E., and Bradfield, C. A. (2005) Induction of P450 enzymes, In Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., ed.), 3rd edn. pp. 323-346, Kluwer Academic Publishers, New York.
69. Keeney, D. S. and Waterman, M. R. (1993) Regulation of steroid hydroxylase gene expression: Importance to physiology and disease, Pharmacol. Ther., 58, 301-317.
70. Nebert, D. W. and Russell, D. W. (2002) Clinical importance of the cytochromes P450, Lancet, 360, 1155-1162.
71. Shimada, T., Yamazaki, H., Foroozesch, M., Hopkins, N. E., Alworth, W. L., and Guengerich, F. P. (1998) Selectivity of polycyclic inhibitors for human cytochromes P450 1A1, 1A2, and 1B1, Chem. Res. Toxicol., 11, 1048-1056.
72. Newton, D. J., Wang, R. W., and Lu, A. Y. H. (1994) Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes, Drug Metab. Dispos., 23, 154-158.
73. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C., and Tukey, R. H. (1990) Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450, Cancer Res., 50, 3367-3376.
74. Yamazaki, H., Inui, Y., Yun, C.-H., Mimura, M., Guengerich, F. P., and Shimada, T. (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes, Carcinogenesis, 13, 1789-1794.
75. Hayes, J. D., Flanagan, J. U., and Jowsey, I. R. (2005) Glutathione transferases, Annu. Rev. Pharmacol. Toxicol., 45, 51-88.
76. Mackenzie, P. I., Gardner-Stephen, D., and Miners, J. O. (2010) UDP-glucuronosyltransferases, In Biotransformation (Guengerich, F. P., ed.), Comprehensive Toxicology, Vol. 4 (McQueen, C. A., series ed.) 2nd edn., pp. 413-433, Elsevier Science Ltd., Oxford, U.K.
77. Marowsky, A., Cronin, A., Frére, F., Adamska, M., and Arand, M. (1997) Mammalian epoxide hydrolases, In Biotransformation (Guengerich, F. P., ed.), Comprehensive Toxicology, Vol. 4 (McQueen, C. A., series ed.) 2nd edn., pp. 275-294, Elsevier Science Ltd., Oxford, U.K.
78. Cashman, J. R. and Zhang, J. (2006) Human flavin-containing monooxygenases, Annu. Rev. Pharmacol. Toxicol., 46, 65-100.
79. Porter, T. D. and Kasper, C. B. (1985) Coding nucleotide sequence of rat NADPH-cytochrome P-450 oxidoreductase cDNA and identification of flavin-binding domains, Proc. Natl. Acad. Sci. USA, 82, 973-977.
80. Williams, R. T. (1959) Detoxication Mechanisms, 2nd edn., Wiley, New York.
81. Josephy, P. D., Guengerich, F. P., and Miners, J. O. (2005) Phase 1 and phase 2 drug metabolism: Terminology that we should phase out, Drug Metab. Dispos., 37, 579-584.
82. Geiger, L. E., Hogy, L. L., and Guengerich, F. P. (1983) Metabolism of acrylonitrile by isolated rat hepatocytes, Cancer Res., 43, 3080-3087.
83. Guengerich, F. P., Geiger, L. E., Hogy, L. L., and Wright, P. L. (1981) In vitro metabolism of acrylonitrile to 2-cyanoethylene oxide, reaction with glutathione, and irreversible binding to proteins and nucleic acids, Cancer Res., 41, 4925-4933.
84. Hogy, L. L. and Guengerich, F. P. (1986) In vivo interaction of acrylonitrile and 2-cyanoethylene oxide with DNA in rats, Cancer Res., 46, 3932-3938.
85. Müller, M., Belas, F. J., Blair, I. A., and Guengerich, F. P. (1997) Analysis of 1, N2-ethenoguanine and 5, 6, 7, 9-tetrahydr o-7-hydroxy-9-oxoimidazo[1, 2-a]purine in DNA treated with 2-chlorooxirane by high performance liquid chromatography/mass spectrometry and comparison of amounts with other adducts, Chem. Res. Toxicol., 10, 242-247.
86. Basu, A. K., Wood, M. L., Niedernhofer, L. J., Ramos, L. A., and Essigmann, J. M. (1993) Mutagenic and genotoxic effects of three vinyl chloride-induced DNAlesions: 1, N6-ethenoadenine, 3, N4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole, Biochemistry, 32, 12793-12801.
87. Langouët, S., Mican, A. N., Müller, M., Fink, S. P., Marnett, L. J., Muhle, S. A., and Guengerich, F. P. (1998) Misincorporation of nucleotides opposite 5-membered exocyclic ring guanine derivatives by Escherichia coli polymerases in vitro and in vivo: 1, N2-ethenoguanine, 5, 6, 7, 9-tetrahydro-9-oxoimidazo[1, 2-a]purine, and 5, 6, 7, 9-tetrahydro-7-hydroxy-9-oxoimidazo[1, 2-a]purine, Biochemistry, 37, 5184-5193.
88. Guengerich, F. P., Crawford, W. M., Jr., and Watanabe, P. G. (1979) Activation of vinyl chloride to covalently bound metabolites: Roles of 2-chloroethylene oxide and 2-chloroacetaldehyde, Biochemistry, 18, 5177-5182.
89. Liebler, D. C. and Guengerich, F. P. (1983) Olefin oxidation by cytochrome P-450: Evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene, Biochemistry, 22, 5482-5489.
90. Miller, R. E. and Guengerich, F. P. (1983) Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450, Cancer Res., 43, 1145-1152.
91. Guengerich, F. P., Mason, P. S., Stott, W. T., Fox, T. R., and Watanabe, P. G. (1981) Roles of 2-haloethylene oxides and 2-haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA, Cancer Res., 41, 4391-4398.
92. van Bladeren, P. J., Breimer, D. D., van Huijgevoort, J. A. T. C. M., Vermeulen, N. P. E., and van der Gen, A. (1981) The metabolic formation of N-acetyl-S-2-hydroxyethyl-l-cysteine from tetradeutero-1, 2-dibromoethane. Relative importance of oxidation and glutathione conjugation in vivo, Biochem. Pharmacol., 30, 2499-2502.
93. Inskeep, P. B., Koga, N., Cmarik, J. L., and Guengerich, F. P. (1986) Covalent binding of 1, 2-dihaloalkanes to DNA and stability of the major DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione, Cancer Res., 46, 2839-2844.
94. Kim, D. H. and Guengerich, F. P. (1989) Excretion of the mercapturic acid S-[2-(N7-guanyl)ethyl]-N-acetylcysteine in urine following administration of ethylene dibromide to rats, Cancer Res., 49, 5843-5851.
95. Peterson, L. A., Harris, T. M., and Guengerich, F. P. (1988) Evidence for an episulfonium ion intermediate in the formation of S-[2-(N7-guanyl)ethyl]glutathione in DNA, J. Am. Chem. Soc., 110, 3284-3291.
96. Guengerich, F. P. (2003) Activation of dihaloalkanes by thioldependent mechanisms, J. Biochem. Mol. Biol., 36, 20-27.
97. Cmarik, J. L., Inskeep, P. B., Meyer, D. J., Meredith, M. J., Ketterer, B., and Guengerich, F. P. (1990) Selectivity of rat and human glutathione S-transferases in activation of ethylene dibromide by glutathione conjugation and DNA binding and induction of unscheduled DNA synthesis in human hepatocytes, Cancer Res., 50, 2747-2752.
98. Ozawa, N. and Guengerich, F. P. (1983) Evidence for formation of an S-[2-(N7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of 1, 2-dibromoethane to DNA, Proc. Natl. Acad. Sci. USA, 80, 5266-5270.
99. Koga, N., Inskeep, P. B., Harris, T. M., and Guengerich, F. P. (1986) S-[2-(N7-Guanyl)ethyl]glutathione, the major DNAadduct formed from 1, 2-dibromoethane, Biochemistry, 25, 2192-2198.
100. Shimada, T., Nakamura, S., Imaoka, S., and Funae, Y. (1987) Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes, Toxicol. Appl. Pharmacol., 91, 13-21.
101. Bolt, H. M. (1979) Metabolism of estrogens-Natural and synthetic, Pharmacol. Ther., 4, 155-181.
102. Shah, R. R., Oates, N. S., Idle, J. R., Smith, R. L., Dayer, P., Courvoisier, F., Balant, L., and Fabre, J. (1982) Betablockers and drug oxidation status, Lancet 319(8270), 508-509.
103. Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., and Hetzel, M. R. (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer, Nature, 312, 169-170.
104. Idle, J. R., Mahgoub, A., Sloan, T. P., Smith, R. L., Mbanefo, C. O., and Bababunmi, E. A. (1981) Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer, Cancer Lett., 11, 331-338.
105. Gonzalez, F. J. and Meyer, U. A. (1991) Molecular genetics of the debrisoquin-sparteine polymorphism, Clin. Pharmacol. Ther., 50, 233-238.
106. Guengerich, F. P. (1977) Studies on the activation of a model furan compound: Toxicity and covalent binding of 2-(N-ethylcarbamoylhydroxymethyl)furan, Biochem. Pharmacol., 26, 1909-1915.
107. van der Hoeven, T. A. and Coon, M. J. (1974) Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes, J. Biol. Chem., 249, 6302-6310.
108. Fang, W. F. and Strobel, H. W. (1978) The drug and carcinogen metabolism system of rat colon microsomes, Arch. Biochem. Biophys., 186, 128-138.
109. 2+-sedimented microsomes from rat liver, Biochem. Pharmacol., 21, 3249-3256.
110. Jernström, B., Capdevila, J., Jakobsson, S., and Orrenius, S. (1975) Solubilization and partial purification of cytochrome P-450 from rat lung microsomes, Biochem. Biophys. Res. Commun., 64, 814-822.
111. Taugen, O., Jonasson, J., and Orrenius, S. (1973) Isolation of rat liver microsomes by gel filtration, Anal. Biochem., 54, 597-603.
112. Wang, P. P., Beaune, P., Kaminsky, L. S., Dannan, G. A., Kadlubar, F. F., Larrey, D., and Guengerich, F. P. (1983) Purification and characterization of six cytochrome P-450isozymes from human liver microsomes, Biochemistry, 22, 5375-5383.
113. Guengerich, F. P. and Mason, P. S. (1979) Immunological comparison of hepatic and extrahepatic cytochromes P-450, Mol. Pharmacol., 15, 154-164.
114. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature, J. Biol. Chem., 239, 2370-2378.
115. Haugen, D. A. and Coon, M. J. (1976) Properties of electrophoretically homogenous phenobarbital-inducible and β-naphthoflavone-inducible forms of liver microsomal cytochrome P-450, J. Biol. Chem., 251, 7929-7939.
116. Ryan, D., Lu, A. Y. H., West, S., and Levin, W. (1975) Multiple forms of cytochrome P-450 in phenobarbital- and 3-methylcholanthrene-treated rats, J. Biol. Chem., 250, 2157-2163.
117. Omura, T. and Sato, R. (1967) Isolation of cytochromes P-450and P-420, Methods Enzymol., 10, 556-561.
118. Matsubara, T., Koike, M., Touchi, A., Tochino, Y., and Sugeno, K. (1976) Quantitative determination of cytochrome P-450 in rat liver homogenate, Anal. Biochem., 75, 596-603.
119. Johannesen, K. A. M. and DePierre, J. W. (1978) Measurements of cytochrome P-450 in the presence of large amounts of contaminating hemoglobin and methemoglobin, Anal. Biochem., 86, 725-732.
120. Phillips, A. H. and Langdon, R. G. (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization, and kinetic studies, J. Biol. Chem., 237, 2652-2660.
121. Vermilion, J. L. and Coon, M. J. (1978) Purified liver microsomal NADPH-cytochrome P-450 reductase: Spectral characterization of oxidation-reduction states, J. Biol. Chem., 253, 2694-2704.
122. Roerig, D. L., Mascaro, L., Jr., and Aust, S. D. (1972) Microsomal electron transport: Tetrazolium reduction by rat liver microsomal NADPH-cytochrome c reductase, Arch. Biochem. Biophys., 153, 475-479.
123. Nash, T. (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction, Biochem. J., 55, 416-421.
124. Cochin, J. and Axelrod, J. (1959) Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine, and normorphine, J. Pharmacol. Exp. Ther., 125, 105-110.
125. Lu, A. Y. H. and West, S. B. (1978) Reconstituted mammalian mixed-function oxidases: Requirements, specificities and other properties, Pharmacol. Ther., 2, 337-358.
126. Guengerich, F. P., Ballou, D. P., and Coon, M. J. (1975) Purified liver microsomal cytochrome P-450: Electronaccepting properties and oxidation-reduction potential, J. Biol. Chem., 250, 7405-7414.
127. Guengerich, F. P. and Holladay, L. A. (1979) Hydrodynamic characterization of highly purified and functionally active liver microsomal cytochrome P-450, Biochemistry, 18, 5442-5449.
128. Thomas, P. E., Bandiera, S., Maines, S. L., Ryan, D. E., and Levin, W. (1987) Regulation of cytochrome P-450j, a highaffinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes, Biochemistry, 26, 2280-2289.
129. Yoo, J. S. H., Guengerich, F. P., and Yang, C. S. (1988) Metabolism of N-nitrosodialkylamines by human liver microsomes, Cancer Res., 48, 1499-1504.
130. Tang, Z. and Guengerich, F. P. (2010) Dansylation of unactivated alcohols for improved mass spectral sensitivity and application to analysis of cytochrome P450 oxidation products in tissue extracts, Anal. Chem., 82, 7706-7712.
131. Lu, A. Y. H., Strobel, H. W., and Coon, M. J. (1970) Properties of a solubilized form of the cytochrome P-450-containing mixed-function oxidase of liver microsomes, Mol. Pharmacol., 6, 213-220.
132. Nordblom, G. D. and Coon, M. J. (1977) Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450, Arch. Biochem. Biophys., 180, 343-347.
133. Gorsky, L. D., Koop, D. R., and Coon, M. J. (1984) On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450: Products of oxygen reduction, J. Biol. Chem., 259, 6812-6817.
134. Greenlee, W. F. and Poland, A. (1978) An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2, 3, 7, 8-tetrachlorodibenzop-dioxin, J. Pharmacol. Exp. Ther., 205, 596-605.
135. Guengerich, F. P. (1978) Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital- and 3-methylcholanthrene-treated rats, J. Biol. Chem., 253, 7931-7939.
136. Nebert, D. W. and Gelboin, H. V. (1968) Substrate-inducible microsomal arylhydroxylase in mammalian cell culture: Assay and properties of induced enzyme, J. Biol. Chem., 243, 6242-6249.
137. Dehnen, W., Tomingas, R., and Roos, J. (1973) A modified method for the assay of benzo[a]pyrene hydroxylase, Anal. Biochem., 53, 373-383.
138. DePierre, J. W., Johannesen, K. A. M., Moron, M. S., and Seidegård, J. (1978) Radioactive assay of aryl hydrocarbon monooxygenase and epoxide hydrase, Methods Enzymol., 52, 412-418.
139. Thakker, D. R., Yagi, H., and Jerina, D. M. (1978) Analysis of polycyclic aromatic hydrocarbons and their metabolites by high-pressure liquid chromatography, Methods Enzymol., 52, 279-296.
140. Bauer, E., Guo, Z., Ueng, Y.-F., Bell, L. C., and Guengerich, F. P. (1995) Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes, Chem. Res. Toxicol., 8, 136-142.
141. Deutsch, J., Leutz, J. C., Yang, S. K., Gelboin, H. V., Chiang, Y. L., Vatsis, K. P., and Coon, M. J. (1978) Regio- and stereoselectivity of various forms of purified cytochrome P-450in the metabolism of benzo[a]pyrene and (-)trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene as shown by product formation and binding to DNA, Proc. Natl. Acad. Sci. USA, 75, 3123-3127.
142. Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., and Waxman, D. J. (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism, J. Biol. Chem., 261, 5051-5060.
143. Böcker, R. H. and Guengerich, F. P. (1986) Oxidation of 4-aryl- and 4-alkyl-substituted 2, 6-dimethyl-3, 5-bis(alkoxycarbonyl)-1, 4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450, J. Med. Chem., 29, 1596-1603.
144. Guengerich, F. P., Brian, W. R., Iwasaki, M., Sari, M.-A., Bäärnhielm, C., and Berntsson, P. (1991) Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4, J. Med. Chem., 34, 1838-1844.
145. Peter, R., Böcker, R. G., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C.-S. (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1, Chem. Res. Toxicol., 3, 566-573.
146. O’Shea, D., Davis, S. N., Kim, R. B., and Wilkinson, G. R. (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chloroxazone: A putative probe of CYP2E1 activity, Clin. Pharmacol. Ther., 56, 359-367.
147. Kim, R. B., Yamazaki, H., Mimura, M., Shimada, T., Guengerich, F. P., Chiba, K., Ishizaki, T., and Wilkinson, G. R. (1996) Chlorzoxazone 6-hydroxylation in Japanese and Caucasians. In vitro and in vivo differences, J. Pharmacol. Exp. Ther., 279, 4-11.
148. Yoo, J. S. H., Cheung, R. J., Patten, C. J., Wade, D., and Yang, C. S. (1987) Nature of N-nitrosodimethylamine demethylase and its inhibitors, Cancer Res., 47, 3378-3383.
149. Chauret, N., Gauthier, A., and Nicoll-Griffith, D. A. (1998) Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes, Drug Metab. Dispos., 26, 1-4.
150. Guengerich, F. P. (1990) Enzymatic oxidation of xenobiotic chemicals, Crit. Rev. Biochem. Mol. Biol., 25, 97-153.
151. Okazaki, O. and Guengerich, F. P. (1993) Evidence for specific base catalysis in N-dealkylation reactions catalyzed by cytochrome P450 and chloroperoxidase: Differences in rates of deprotonation of aminium radicals as an explanation for high kinetic hydrogen isotope effects observed with peroxidases, J. Biol. Chem., 268, 1546-1552.
152. Guengerich, F. P., Yun, C.-H., and Macdonald, T. L. (1996) Evidence for a one-electron oxidation mechanism in N-dealkylation of N, N-dialkylanilines by cytochrome P4502B1. Kinetic hydrogen isotope effects, linear free energy relationships, comparisons with horseradish peroxidase, and studies with oxygen surrogates, J. Biol. Chem., 271, 27321-27329.
153. Miwa, G. T., Walsh, J. S., Kedderis, G. L., and Hollenberg, P. F. (1983) The use of intramolecular isotope effects to distinguish between deprotonation and hydrogen atom abstraction mechanisms in cytochrome P-450- and peroxidase-catalyzed N-demethylation reactions, J. Biol. Chem., 258, 14445-14449.
154. Bell, L. C. and Guengerich, F. P. (1997) Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics, J. Biol. Chem., 272, 29643-29651.
155. Guengerich, F. P. and Kim, D.-H. (1991) Enzymatic oxidation of ethyl carbamate to vinyl carbamate and its role as an intermediate in the formation of 1, N6-ethenoadenosine, Chem. Res. Toxicol., 4, 413-421.
156. Dahl, G. A., Miller, J. A., and Miller, E. C. (1978) Vinyl carbamate as a promutagen and a more carcinogenic analog of ethyl carbamate, Cancer Res., 38, 3793-3804.
157. Dahl, G. A., Miller, E. C., and Miller, J. A. (1980) Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate, Cancer Res., 40, 1194-1203.
158. Leithauser, M. T., Liem, A., Stewart, B. C., Miller, E. C., and Miller, J. A. (1990) 1, N6-Ethenoadenosine formation, mutagenicity and murine tumor induction as indicators of the generation of an electrophilic epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate, Carcinogenesis, 11, 463-473.
159. Udenfriend, S. (1969) Fluorescence Assay in Biology and Medicine, Academic Press, New York.
160. Rinkus, S. J. and Legator, M. S. (1985) Fluorometric assay using high-pressure liquid chromatography for the microsomal metabolism of certain substituted aliphatic to 1, N6-ethenoadenineforming metabolites, Anal. Biochem., 150, 379-393.
161. Mitoma, C., Yasuda, D. M., Tagg, J., and Tanabe, M. (1967) Effect of deuteration of the O-CH3 group on the enzymic demethylation of o-nitroanisole, Biochim. Biophys. Acta, 136, 566-567.
162. Miller, G. P. and Guengerich, F. P. (2001) Binding and oxidation of alkyl 4-nitrophenyl ethers by rabbit cytochrome P450 1A2: Evidence for two binding sites, Biochemistry, 40, 7262-7272.
163. Yamano, S., Tatsuno, J., and Gonzalez, F. J. (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes, Biochemistry, 29, 1322-1329.
164. Yun, C.-H., Shimada, T., and Guengerich, F. P. (1991) Purification and characterization of human liver microsomal cytochrome P-450 2A6, Mol. Pharmacol., 40, 679-685.
165. Yun, C.-H., Kim, K.-H., Calcutt, M. W., and Guengerich, F. P. (2005) Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6, J. Biol. Chem., 280, 12279-12291.
166. Wandel, C., Witte, J. S., Hall, J. M., Stein, C. M., Wood, A. J., and Wilkinson, G. R. (2000) CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B5′-promoter region polymorphism, Clin. Pharmacol. Ther., 68, 82-91.
167. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent, J. Biol. Chem., 243, 1331-1332.
168. Brown, R. E., Jarvis, K. L., and Hyland, K. J. (1989) Protein measurement using bicinchoninic acid: Elimination of interfering substances, Anal. Biochem., 180, 136-139.
169. Sun, J. D. and Dent, J. G. (1980) A new method for measuring covalent binding of chemicals to cellular macromolecules, Chem. Biol. Interact., 32, 41-61.
170. Wallin, H., Schelin, C., Tunek, A., and Jergil, B. (1981) Arapid and sensitive method for determination of covalent binding of benzo[a]pyrene to proteins, Chem. Biol. Interact., 38, 109-118.
171. Guengerich, F. P., Crawford, W. M., Jr., Domoradzki, J. Y., Macdonald, T. L., and Watanabe, P. G. (1980) In vitro activation of 1, 2-dichloroethane by microsomal and cytosolic enzymes, Toxicol. Appl. Pharmacol., 55, 303-317.
172. Inskeep, P. B. and Guengerich, F. P. (1984) Glutathionemediated binding of dibromoalkanes to DNA: Specificity of rat glutathione S-transferases and dibromoalkane structure, Carcinogenesis, 5, 805-808.
173. Dische, Z. (1955) Color reactions of nucleic acid components, In The Nucleic Acids, Vol. 1 (Chargoff, E. and Davidson, J. N., eds.), pp. 285-305, Academic Press, New York.
174. Cerasone, C. F., Bolognesi, C., and Santi, L. (1979) Improved microfluorometric DNA determinations in biological material using 33258 Hoechst, Anal. Biochem., 100, 188-197.
175. Shimada, T., Oda, Y., Yamazaki, H., Mimura, M., and Guengerich, F. P. (1994) SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009, In Methods in Molecular Genetics, Vol. 5, Gene and Chromosome Analysis (Adolph, K. W., ed.), pp. 342-355, Academic Press, Orlando, FL.
176. Josephy, P. D., Evans, D. H., Parikh, A., and Guengerich, F. P. (1998) Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli, Chem. Res. Toxicol. 11, 70-74.
177. Randerath, K., Reddy, M. V., and Gupta, R. C. (1981) 32P-labeling test for DNA damage, Proc. Natl. Acad. Sci. USA, 78, 6126-6129.
178. Sheabar, F. Z., Morningstar, M. L., and Wogan, G. N. (1994) Adduct detection by acylation with [35S]methionine: Analysis of DNA adducts of 4-aminobiphenyl, Proc. Natl. Acad. Sci. USA, 91, 1696-1700.
179. Guengerich, F. P., Sorrells, J. L., Schmitt, S., Krauser, J. A., Aryal, P., and Meijer, L. (2004) Generation of new protein kinase inhibitors utilizing cytochrome P450 mutant enzymes for indigoid coupling, J. Med. Chem., 43, 3236-3241.
180. Jaffe, H. H. and Orchin, M. (1962) Theory and Applications of Ultraviolet Spectroscopy, 1st edn., John Wiley and Sons, New York.
181. Silverstein, R. M., Bassler, G. C., and Morrill, T. C. (1991) Spectrometric Identification of Organic Compounds, Vol. 7, 5th edn., John Wiley and Sons, New York.
182. Dyer, J. R. (1965) Applications of Absorption Spectroscopy of Organic Compounds, Prentice Hall, Englewood Cliffs, NJ.
183. Guengerich, F. P., Voehler, M., Williams, K. M., Deng, Z., and Harris, T. M. (2002) Structure of aflatoxin B1 dialdehyde adduct formed from reaction with methylamine, Chem. Res. Toxicol., 15, 793-798.
184. Krauser, J. A., Voehler, M., Tseng, L.-H., Schefer, A. B., Godejohann, M., and Guengerich, F. P. (2004) 1β-Hydroxylation of testosterone by human cytochrome P450 3A4, Eur. J. Biochem., 271, 3962-3969.
185. Woody, R. W. (1995) Circular dichroism, Methods Enzymol., 246, 34-71.
186. Meyring, M., Muhlbacher, J., Messer, K., Kastner-Pustet, N., Bringmann, G., Mannschreck, A., and Blaschke, G. (2002) In vitro biotransformation of (R)- and (S)-thalidomide: Application of circular dichroism spectroscopy to the stereochemical characterization of the hydroxylated metabolites, Anal. Chem., 74, 3726-3735.
187. Zhu, M., Zhang, H., and Humphreys, W. G. (2011) Drug metabolite profiling and identification by high-resolution mass spectrometry, J. Biol. Chem., 286, 25419-25425.
188. Rabenstein, D. L. (2001) NMR spectroscopy: Past and present, Anal. Chem. 73, 214A-223A.
189. Gottlieb, H. E., Kotlyar, V., and Nudelman, A. (1997) NMRchemical shifts of common laboratory solvents as trace impurities, J. Org. Chem., 62, 7512-7515.
190. Wu, Z., Aryal, P., Lozach, O., Meijer, L., and Guengerich, F. P. (2005) Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6, Chem. Biodivers., 2, 51-65.
191. Goeddel, D. W., ed. (1990) Methods in Enzymology, Vol. 185, Gene Expression Technology, Academic Press, San Diego, CA.
192. Waterman, M. R. and Johnson, E. F., eds. (1991) Methods in Enzymology, Vol. 206, Cytochrome P450, Academic Press, San Diego, CA.
193. Guengerich, F. P., Gillam, E. M. J., and Shimada, T. (1996) New applications of bacterial systems to problems in toxicology, CRC Crit. Rev. Toxicol., 26, 551-583.
194. Langouët, S., Furge, L. L., Kerriguy, N., Nakamura, K., Guillouzo, A., and Guengerich, F. P. (2000) Inhibition of human cytochrome P450 enzymes by 1, 2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane, Chem. Res. Toxicol., 13, 245-252.
195. Parikh, A., Josephy, P. D., and Guengerich, F. P. (1999) Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties, Biochemistry, 38, 5283-5289.
196. Jensen, K. G., Poulsen, H. E., Doehmer, J., and Loft, S. (1996) Paracetamol-induced spindle disturbances in V79 cells with and without expression of human CYP1A2, Pharmacol. Toxicol., 78, 224-228.
197. Hosea, N. A., Miller, G. P., and Guengerich, F. P. (2000) Elucidation of distinct binding sites for cytochrome P450 3A4, Biochemistry, 39, 5929-5939.
198. Guengerich, F. P. and Martin, M. V. (2006) Purification of cytochrome P450: Products of bacterial recombinant expression systems, In Methods in Molecular Genetics, Cytochrome P450 Protocols (Phillips, I. R. and Shephard, E., eds.), pp. 31-37, Academic Press, Orlando, FL.
199. Hanna, I. H., Dawling, S., Roodi, N., Guengerich, F. P., and Parl, F. (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity, Cancer Res., 60, 3440-3444.
200. Barnes, H. J., Arlotto, M. P., and Waterman, M. R. (1991) Expression and enzymatic activity of recombinant cytochrome P450 17α-hydroxylase in Escherichia coli, Proc. Natl. Acad. Sci. USA 88, 5597-5601.
201. Thier, R., Pemble, S. E., Taylor, J. B., Humphreys, W. G., Persmark, M., Ketterer, B., and Guengerich, F. P. (1993) Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes, Proc. Natl. Acad. Sci. USA 90, 8576-8580.
202. Josephy, P. D., DeBruin, L. S., Lord, H. L., Oak, J., Evans, D. H., Guo, Z., Dong, M.-S., and Guengerich, F. P. (1995) Bioactivation of aromatic amines by recombinant human cytochrome P450 1A2 expressed in bacteria: A substitute for mammalian tissue preparations in mutagenicity testing, Cancer Res., 55, 799-802.
203. Suzuki, A., Kushida, H., Iwata, H., Watanabe, M., Nohmi, T., Fujita, K., Gonzalez, F. J., and Kamataki, T. (1998) Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines, Cancer Res., 58, 1833-1838.
204. Barnes, H. J. (1996) Maximizing expression of eukaryotic cytochrome P450s in Escherichia coli, Methods Enzymol. 272, 3-14.
205. Kusano, K., Waterman, M. R., Sakaguchi, M., Omura, T., and Kagawa, N. (1999) Protein synthesis inhibitors and ethanol selectively enhance heterologous expression of P450s and related proteins in Escherichia coli, Arch. Biochem. Biophys. 367, 129-136.
206. Gellissen, G., Janowicz, Z. A., Weydemann, U., Melber, K., Strasser, A. W., and Hollenberg, C. P. (1992) High-level expression of foreign genes in Hansenula polymorpha, Biotechnol. Adv. 10, 179-189.
207. Guengerich, F. P., Brian, W. R., Sari, M.-A., and Ross, J. T. (1991) Expression of mammalian cytochrome P450 enzymes using yeast-based vectors, Methods Enzymol., 206, 130-145.
208. Loeper, J., Louérat-Oriou, B., Duport, C., and Pompon, D. (1998) Yeast expressed cytochrome P450 2D6 (CYP2D6)exposed on the external face of plasma membrane is functionally competent, Mol. Pharmacol., 54, 8-13.
209. Marques-Soares, C., Dijols, S., Macherey, A.-C., Wester, M. R., Johnson, E. F., Dansette, P. M., and Mansuy, D. (2003) Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochrome P450 2Cs: Identification of a new high affinity substrate common to those CYP 2Cenzymes, Biochemistry, 42, 6363-6369.
210. Newton-Vinson, P., Hubalek, F., and Edmondson, D. E. (2000) High-level expression of human liver monoamine oxidase Bin Pichia pastoris, Protein Expr. Purif. 20, 334-345.
211. Reddy, R. G., Yoshimoto, T., Yamamoto, S., and Marnett, L. J. (1994) Expression, purification, and characterization of porcine leukocyte 12-lipoxygenase produced in the methyltrophic yeast, Pichia pastoris, Biochem. Biophys. Res. Commun., 205, 381-388.
212. Brian, W. R., Srivastava, P. K., Umbenhauer, D. R., Lloyd, R. S., and Guengerich, F. P. (1989) Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae, Biochemistry, 28, 4993-4999.
213. Brian, W. R., Sari, M.-A., Iwasaki, M., Shimada, T., Kaminsky, L. S., and Guengerich, F. P. (1990) Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae, Biochemistry, 29, 11280-11292.
214. Miller, L. K. (1988) Baculoviruses as gene expression vectors, Annu. Rev. Microbiol., 42, 177-199.
215. Tamura, S., Korzekwa, K. R., Kimura, S., Gelboin, H. V., and Gonzalez, F. J. (1992) Baculovirus-mediated expression and functional characterization of human NADPH-P450 oxidoreductase, Arch. Biochem. Biophys., 293, 219-223.
216. Zuber, M. X., Simpson, E. R., and Waterman, M. R. (1986) Expression of bovine 17α-hydroxylase cytochrome P-450 cDNAin nonsteroidogenic (COS 1) cells, Science, 234, 1258-1261.
217. Gonzalez, F. J., Aoyama, T., and Gelboin, H. V. (1991) Expression of mammalian cytochrome P450 using vaccinia virus, Methods Enzymol., 206, 85-92.
218. Kimchi-Sarfaty, C., Gribar, J. J., and Gottesman, M. M. (2002) Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system, Mol. Pharmacol., 62, 1-6.
219. Gonzalez, F. J. and Kimura, S. (2003) Study of P450 function using gene knockout and transgenic mice, Arch. Biochem. Biophys., 409, 153-158.
220. Guengerich, F. P. (1987) Enzymology of rat liver cytochromes P-450, In Mammalian Cytochromes P-450, Vol. 1 (Guengerich, F. P., ed.), pp. 1-54, CRC Press, Boca Raton, FL.
221. Guengerich, F. P., Distlerath, L. M., Reilly, P. E. B., Wolff, T., Shimada, T., Umbenhauer, D. R., and Martin, M. V. (1986) Human liver cytochromes P-450 involved in polymorphisms of drug oxidation, Xenobiotica, 16, 367-378.
222. Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., Gonzalez, F. J. et al. (1991) The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature, DNA Cell Biol., 10, 1-14.
223. Guengerich, F. P., Hosea, N. A., Parikh, A., Bell-Parikh, L. C., Johnson, W. W., Gillam, E. M. J., and Shimada, T. (1998) Twenty years of biochemistry of human P450s: Purification, expression, mechanism, and relevance to drugs, Drug Metab. Dispos., 26, 1175-1178.
224. Halpert, J. R., Guengerich, F. P., Bend, J. R., and Correia, M. A. (1994) Selective inhibitors of cytochromes P450, Toxicol. Appl. Pharmacol., 125, 163-175.
225. Shimada, T. and Guengerich, F. P. (1985) Participation of a rat liver cytochrome P-450 induced by pregnenolone 16α-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin, Mol. Pharmacol., 28, 215-219.
226. Beaune, P., Kremers, P. G., Kaminsky, L. S., de Graeve, J., and Guengerich, F. P. (1986) Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes, Drug Metab. Dispos., 14, 437-442.
227. Guengerich, F. P. and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450enzymes, Chem. Res. Toxicol., 4, 391-407.
228. Butler, M. A., Iwasaki, M., Guengerich, F. P., and Kadlubar, F. F. (1989) Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines, Proc. Natl. Acad. Sci. USA, 86, 7696-7700.
229. Distlerath, L. M. and Guengerich, F. P. (1984) Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs using antibodies raised to the analogous rat enzyme, Proc. Natl. Acad. Sci. USA, 81, 7348-7352.
230. Thomas, P. E., Lu, A. Y. H., West, S. B., Ryan, D., Miwa, G. T., and Levin, W. (1977) Accessibility of cytochrome P450 in microsomal membranes: Inhibition of metabolism by antibodies to cytochrome P450, Mol. Pharmacol., 13, 819-831.
231. Kaminsky, L. S., Fasco, M. J., and Guengerich, F. P. (1981) Production and application of antibodies to rat liver cytochrome P-450, Methods Enzymol., 74, 262-272.
232. Soucek, P., Martin, M. V., Ueng, Y.-F., and Guengerich, F. P. (1995) Identification of a common epitope near the conserved heme-binding region with polyclonal antibodies raised against cytochrome P450 family 2 proteins, Biochemistry, 34, 16013-16021.
233. Fujino, T., Park, S. S., West, D., and Gelboin, H. V. (1982) Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies, Proc. Natl. Acad. Sci. USA, 79, 3682-3686.
234. Gelboin, H. V. (1993) Cytochrome P450 and monoclonal antibodies, Pharmacol. Rev., 45, 413-453.
235. Thomas, P. E., Reidy, J., Reik, L. M., Ryan, D. E., Koop, D. R., and Levin, W. (1984) Use of monoclonal antibody probes against rat hepatic cytochromes P-450c and P-450d to detect immunochemically related isozymes in liver microsomes from different species, Arch. Biochem. Biophys., 235, 239-253.
236. Cribb, A., Nuss, C., and Wang, R. (1995) Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6, Drug Metab. Dispos., 23, 671-675.
237. Wang, R. W. and Lu, A. Y. H. (1997) Inhibitory anti-peptide antibody against human CYP3A4, Drug Metab. Dispos., 25, 762-767.
238. Baca, M., Scanlan, T. S., Stephenson, R. C., and Wells, J. A. (1997) Phage display of a catalytic antibody to optimize affinity for transition-state analog binding, Proc. Natl. Acad. Sci. USA, 94, 10063-10068.
239. Walsh, C. (1979) Enzymatic Reaction Mechanisms, W.H. Freeman Co., San Francisco, CA.
240. Northrop, D. B. (1998) On the meaning of Km and V/K in enzyme kinetics, J. Chem. Ed., 75, 1153-1157.
241. Kyte, J. (1995) Mechanism in Protein Chemistry, Vol. 3, 1st edn., Garland, New York.
242. Renwick, A. G. (2007) Toxicokinetics: Pharmacokinetics in toxicology, In Principles and Methods of Toxicology (Hayes, A. W., ed.) 5th edn., pp. 179-230, Raven Press, New York.
243. Andersen, M. E., Clewell, H. J., and Frederick, C. B. (1995) Applying simulation modeling to problems in toxicology and risk assessment-A short perspective, Toxicol. Appl. Pharmacol., 133, 181-187.
244. Gillam, E. M. J., Baba, T., Kim, B.-R., Ohmori, S., and Guengerich, F. P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme, Arch. Biochem. Biophys., 305, 123-131.
245. Guengerich, F. P., Martin, M. V., Guo, Z., and Chun, Y.-J. (1996) Purification of recombinant human cytochrome P450enzymes expressed in bacteria, Methods Enzymol., 272, 35-44.
246. Domanski, T. L., Liu, J., Harlow, G. R., and Halpert, J. R. (1998) Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: Role in steroid hydroxylase activity and α-naphthoflavone stimulation, Arch. Biochem. Biophys., 350, 223-232.
247. Guengerich, F. P., Hosea, N. A., and Martin, M. V. (1998) Purification of P450s. Products of bacterial recombinant systems, In Methods in Molecular Genetics, Vol. 107, Cytochrome P450 Protocols (Phillips, I. R. and Shephard, E., eds.), pp. 77-83, Academic Press, Orlando, FL.
248. Porath, J. (1992) Immobilized metal ion affinity chromatography, Protein Expr. Purif., 3, 263-281.
249. Porath, J., Carlsson, J., Olsson, I., and Belfrage, G. (1975) Metal chelate affinity chromatography, a new approach to protein fractionation, Nature, 258, 598-599.
250. Jenkins, C. M. and Waterman, M. R. (1994) Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities, J. Biol. Chem., 269, 27401-27408.
251. Imai, T., Globerman, H., Gertner, J. M., Kagawa, N., and Waterman, M. R. (1993) Expression and purification of functional human 17α-hydroxylase/17, 20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17α-hydroxylase/17, 20-lyase deficiency, J. Biol. Chem., 268, 19681-19689.
252. Kempf, A., Zanger, U. M., and Meyer, U. A. (1995) Truncated human P450 2D6: Expression in Escherichia coli: Ni2+-chelate affinity purification, and characterization of solubility and aggregation, Arch. Biochem. Biophys., 321, 277-288.
253. Sandhu, P., Baba, T., and Guengerich, F. P. (1993) Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity, Arch. Biochem. Biophys., 306, 443-450.
254. Gillam, E. M. J., Guo, Z., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties, Arch. Biochem. Biophys., 312, 59-66.
255. Gillam, E. M. J., Guo, Z., Ueng, Y.-F., Yamazaki, H., Cock, I., Reilly, P. E. B., Hooper, W. D., and Guengerich, F. P. (1995) Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5′ modifications, purification, spectral characterization, reconstitution conditions, and catalytic activities, Arch. Biochem. Biophys., 317, 374-384.
256. Guo, Z., Gillam, E. M. J., Ohmori, S., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 1A1 in Escherichia coli: Effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties, Arch. Biochem. Biophys., 312, 436-446.
257. Hosea, N. A. and Guengerich, F. P. (1998) Oxidation of non-ionic detergents by cytochrome P450 enzymes, Arch. Biochem. Biophys., 353, 365-373.
258. Yun, C.-H., Miller, G. P., and Guengerich, F. P. (2000) Ratedetermining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants, Biochemistry, 39, 11319-11329.
259. Kim, D. and Guengerich, F. P. (2004) Selection of human cytochrome P450 1A2 mutants with selectivity enhanced catalytic activity for heterocyclic amine N-hydroxylation, Biochemistry, 43, 981-988.
260. Sohl, C. D. and Guengerich, F. P. (2010) Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1, J. Biol. Chem., 285, 17734-17743.
261. Hanna, I. H., Kim, M.-S., and Guengerich, F. P. (2001) Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation. The role of aspartate 301 in structural integrity, Arch. Biochem. Biophys., 393, 255-261.
262. Chun, Y.-J., Kim, S., Kim, D., Lee, S.-K., and Guengerich, F. P. (2001) A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis, Cancer Res., 61, 8164-8170.
263. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680-685.
264. Yasukochi, Y. and Masters, B. S. S. (1976) Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography, J. Biol. Chem., 251, 5337-5344.
265. Strobel, H. W. and Dignam, J. D. (1978) Purification and properties of NADPH-cytochrome P-450 reductase, Methods Enzymol., 52, 89-96.
266. Guengerich, F. P. (1977) Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest, J. Biol. Chem., 252, 3970-3979.
267. Guengerich, F. P. (1977) Preparation and properties of highly purified cytochrome P-450 and NADPH-cytochrome P-450reductase from pulmonary microsomes of untreated rabbits, Mol. Pharmacol., 13, 911-923.
268. Guengerich, F. P. and Martin, M. V. (1980) Purification of cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydratase from a single preparation of rat liver microsomes, Arch. Biochem. Biophys., 205, 365-379.
269. Imai, Y. (1976) The use of 8-aminooctyl sepharose for the separation of some components of the hepatic microsomal electron transfer system, J. Biochem. (Tokyo), 80, 267-276.
270. Imai, Y. and Sato, R. (1974) A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits, Biochem. Biophys. Res. Commun., 60, 8-14.
271. Wang, P., Mason, P. S., and Guengerich, F. P. (1980) Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver, Arch. Biochem. Biophys., 199, 206-219.
272. Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F. (1998) Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxidesupported activities, Arch. Biochem. Biophys., 350, 324-332.
273. Guengerich, F. P. (1978) Destruction of heme and hemoproteins mediated by liver microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase, Biochemistry, 17, 3633-3639.
274. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248-254.
275. Furge, L. L. and Guengerich, F. P. (1999) Explanation of presteady-state kinetics and decreased burst amplitude of HIV-1reverse transcriptase at sites of modified DNA bases with an additional non-productive enzyme-DNA-nucleotide complex, Biochemistry, 38, 4818-4825.
276. Segel, I. H. (1976) Biochemical Calculations: How to Solve Mathematical Problems in General Biochemistry, 2nd edn., John Wiley and Sons, New York.
277. Einolf, H. J. and Guengerich, F. P. (2000) Kinetic analysis of nucleotide incorporation by mammalian DNA polymerase δ, J. Biol. Chem., 275, 16316-16322.
278. Bligh, E. G. and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol., 37, 911-917.
279. Chen, P. S., Jr., Toribara, T. Y., and Warner, H. (1956) Microdetermination of phosphorus, Anal. Chem., 28, 1756-1758.
280. Garewal, H. S. (1973) A procedure for the estimation of microgram quantities of Triton X-100, Anal. Biochem., 54, 319-324.
281. Goldstein, S. and Blecher, M. (1975) The spectrophotometric assay for the polyethoxy nonionic detergents in membrane extracts: A critique, Anal. Biochem., 64, 130-135.
282. Sadano, H. and Omura, T. (1983) Reversible transfer of heme between different molecular species of microsomebound cytochrome P-450 in rat liver, Biochem. Biophys. Res. Commun., 116, 1013-1019.
283. Dannan, G. A. and Guengerich, F. P. (1982) Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues, Mol. Pharmacol., 22, 787-794.
284. Guengerich, F. P. (1979) Artifacts in isoelectric focusing of the microsomal enzymes cytochrome P-450 and NADPH-cytochrome P-450 reductase, Biochim. Biophys. Acta, 577, 132-141.
285. Guengerich, F. P. (1979) Isolation and purification of cytochrome P-450, and the existence of multiple forms, Pharmacol. Ther., 6, 99-121.
286. O’Farrell, P. Z., Goodman, H. M., and O’Farrell, P. H. (1977) High resolution two-dimensional electrophoresis of basic as well as acidic proteins, Cell, 12, 1133-1142.
287. Vlasuk, G. P. and Walz, F. G., Jr. (1980) Liver endoplasmic reticulum polypeptides resolved by two-dimensional gel electrophoresis, Anal. Biochem., 105, 112-120.
288. Guengerich, F. P., Wang, P., and Mason, P. S. (1981) Immunological comparison of rat, rabbit, and human liver NADPH-cytochrome P-450 reductases, Biochemistry, 20, 2379-2385.
289. Guengerich, F. P., Wang, P., Mason, P. S., and Mitchell, M. B. (1981) Immunological comparison of rat, rabbit, and human microsomal cytochromes P-450, Biochemistry, 20, 2370-2378.
290. Thomas, P. E., Ryan, D., and Levin, W. (1976) An improved staining procedure for the detection of the peroxidase activity of cytochrome P-450 on sodium dodecyl sulfate polyacrylamide gels, Anal. Biochem., 75, 168-176.
291. Lu, A. Y. H. and Levin, W. (1974) The resolution and reconstitution of the liver microsomal hydroxylation system, Biochim. Biophys. Acta, 344, 205-240.
292. Lu, A. Y. H., Levin, W., and Kuntzman, R. (1974) Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. VII. Stimulation of benzphetamine N-demethylation by lipid and detergent, Biochem. Biophys. Res. Commun., 60, 266-272.
293. French, J. S., Guengerich, F. P., and Coon, M. J. (1980) Interactions of cytochrome P-450, NADPH-cytochrome P-450 reductase, phospholipid, and substrate in the reconstituted liver microsomal enzyme system, J. Biol. Chem., 255, 4112-4119.
294. Guengerich, F. P. and Strickland, T. W. (1977) Metabolism of vinyl chloride: Destruction of the heme of highly purified liver microsomal cytochrome P-450 by a metabolite, Mol. Pharmacol., 13, 993-1004.
295. Ziegler, D. M. (1988) Flavin-containing monooxygenases: Catalytic mechanism and substrate specificities, Drug Metab. Rev., 19, 1-32.
296. Ziegler, D. M. (1993) Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases, Annu. Rev. Pharmacol. Toxicol., 33, 179-199.
297. Ziegler, D. M. (1980) Microsomal flavin-containing monooxygenase: Oxygenation of nucleophilic nitrogen and sulfur compounds, In Enzymatic Basis of Detoxication, Vol. 1 (Jakoby, W. B., ed.), pp. 201-227, Academic Press, New York.
298. Knodell, R. G., Browne, D., Gwodz, G. P., Brian, W. R., and Guengerich, F. P. (1991) Differential inhibition of human liver cytochromes P-450 by cimetidine, Gastroenterology, 101, 1680-1691.
299. Dean, W. L. and Coon, M. J. (1977) Immunochemical studies on two electrophoretically homogeneous forms of rabbit liver microsomal cytochrome P-450: P-450LM2 and P-450LM4, J. Biol. Chem., 252, 3255-3261.
300. Johnson, E. F. and Muller-Eberhard, U. (1977) Multiple forms of cytochrome P-450: Resolution and purification of rabbit liver aryl hydrocarbon hydroxylase, Biochem. Biophys. Res. Commun., 76, 644-651.
301. Kaminsky, L. S., Fasco, M. J., and Guengerich, F. P. (1979) Comparison of different forms of liver, kidney, and lung microsomal cytochrome P-450 by immunological inhibition of regio- and stereoselective metabolism of warfarin, J. Biol. Chem., 254, 9657-9662.
302. Kaminsky, L. S., Fasco, M. J., and Guengerich, F. P. (1980) Comparison of different forms of purified cytochrome P-450from rat liver by immunological inhibition of regio- and stereoselective metabolism of warfarin, J. Biol. Chem., 255, 85-91.
303. Masters, B. S. S., Baron, J., Taylor, W. E., Isaacson, E. L., and LoSpalluto, J. (1971) Immunochemical studies on electron transport chains involving cytochrome P-450. I. Effects of antibodies to pig liver microsomal reduced triphosphopyridine nucleotide-cytochrome c reductase and the non-heme iron protein from bovine adrenocortical mitochondria, J. Biol. Chem., 246, 4143-4150.
304. Bentley, P. and Oesch, F. (1975) Purification of rat liver epoxide hydratase to apparent homogeneity, FEBS Lett., 59, 291-295.
305. Johnson, E. F. and Muller-Eberhard, U. (1977) Resolution of two forms of cytochrome P-450 from liver microsomes of rabbits treated with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin, J. Biol. Chem., 252, 2839-2845.
306. Johnson, E. F. and Muller-Eberhard, U. (1977) Purification of the major cytochrome P-450 of liver microsomes from rabbits treated with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD), Biochem. Biophys. Res. Commun., 76, 652-659.
307. Ryan, D. E., Thomas, P. E., Korzeniowski, D., and Levin, W. (1979) Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene, J. Biol. Chem., 254, 1365-1374.
308. Thomas, P. E., Koreniowski, D., Ryan, D., and Levin, W. (1979) Preparation of monospecific antibodies against two forms of rat liver cytochrome P-450 and quantitation of these antigens in microsomes, Arch. Biochem. Biophys., 192, 524-532.
309. De Lemos-Chiarandini, C., Frey, A. B., Sabatini, D. D., and Kreibich, G. (1987) Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4 using site-specific antibodies, J. Cell Biol., 104, 209-219.
310. Kawabata, T. T., Guengerich, F. P., and Baron, J. (1981) An immunohistochemical study on the localization and distribution of epoxide hydrolase within livers of untreated rats, Mol. Pharmacol., 20, 709-714.
311. Shen, J., Moy, J. A., Green, M. D., Guengerich, F. P., and Baron, J. (1998) Immunohistochemical demonstration of β-naphthoflavone-inducible cytochrome P450 1A1/1A2 in rat intrahepatic biliary epithelial cells, Hepatology, 27, 1483-1491.
312. Milstein, C. (1981) From antibody diversity to monoclonal antibodies, Eur. J. Biochem., 118, 429-436.
313. Gill, T. J., III (1972) The chemistry of antigens and its influence on immunogenicity, In Imunogenicity (Borek, F., ed.), pp. 5-44, American Elsevier, New York.
314. Distlerath, L. M., Reilly, P. E. B., Martin, M. V., Davis, G. G., Wilkinson, G. R., and Guengerich, F. P. (1985) Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism, J. Biol. Chem., 260, 9057-9067.
315. Shimada, T., Misono, K. S., and Guengerich, F. P. (1986) Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction, J. Biol. Chem., 261, 909-921.
316. Oesch, F. and Bentley, P. (1976) Antibodies against homogeneous epoxide hydratase provide evidence for a single enzyme hydrating styrene oxide and benz(a)pyrene 4, 5-oxide, Nature, 259, 53-55.
317. Park, S. S., Fujino, T., Miller, H., Guengerich, F. P., and Gelboin, H. V. (1984) Monoclonal antibodies to phenobarbital-induced rat liver cytochrome P-450, Biochem. Pharmacol., 33, 2071-2081.
318. Park, S. S., Fujino, T., West, D., Guengerich, F. P., and Gelboin, H. V. (1982) Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450, Cancer Res., 42, 1798-1808.
319. Paye, M., Beaune, P., Kremers, P., Frankinet-Collignon, C., Guengerich, F. P., Goujon, F., and Gielen, J. (1984) Quantification of two cytochrome P-450 isoenzymes by an enzyme-linked immunosorbent assay (ELISA), Biochem. Biophys. Res. Commun., 122, 137-142.
320. Choi, J.-Y., Eoff, R. L., Wang, J., Pence, M. G., Martin, M. V., Folkmann, L. M., and Guengerich, F. P. (2010) Roles of the four DNA polymerases of the crenarchaeon Sulfolobus solfataricus and accessory proteins in DNA replication, J. Biol. Chem., 286, 31180-31193.
321. Shaw, P. M., Reiss, A., Adesnik, M., Nebert, D. W., Schembri, J., and Jaiswal, A. K. (1991) The human dioxininducible NAD(P)H:quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4, Eur. J. Biochem., 195, 171-176.
322. Towbin, H., Staehelin, T., and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications, Proc. Natl. Acad. Sci. USA, 76, 4350-4354.
323. Gershoni, J. M. and Palade, G. E. (1983) Protein blotting: Principles and applications, Anal. Biochem., 131, 1-15.
324. Towbin, H. and Gordon, J. (1984) Immunoblotting and dot immunobinding-current status and outlook, J. Immunol. Methods, 72, 313-340.
325. Steward, A. R., Dannan, G. A., Guzelian, P. S., and Guengerich, F. P. (1985) Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes, Mol. Pharmacol., 27, 125-132.
326. Nisar, S., Lane, C. S., Wilderspin, A. F., Welham, K. J., Griffiths, W. J., and Patterson, L. H. (2004) A proteomic approach to the identification of cytochrome P450 isoforms in male and female rat liver by nanoscale liquid chromatography-electrospray ionization-tandem mass spectrometry, Drug Metab. Dispos., 32, 382-386.
327. Zhang, H., Liu, Q., Zimmerman, L. J., Ham, A. J., Slebos, R. J., Rahman, J., Kikuchi, T. et al. (2011) Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry, Mol. Cell Proteom. 10, M110 006593.
328. Simmons, D. L., McQuiddy, P., and Kasper, C. B. (1987) Induction of the hepatic mixed-function oxidase system by synthetic glucocorticoids. Transcriptional and post-transcriptional regulation, J. Biol. Chem., 262, 326-332.
329. Song, B. J., Gelboin, H. V., Park, S. S., Yang, C. S., and Gonzalez, F. J. (1986) Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s: Transcriptional and post-transcriptional regulation of the rat enzyme, J. Biol. Chem., 261, 16689-16697.
330. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156-159.
331. Chomczynski, P. and Mackey, K. (1995) Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation, Anal. Biochem., 225, 163-164.
332. Kingston, R. E., Chomczynski, P., and Sacchi, N. (1996) Guanidine methods for total RNA preparation, Curr. Protoc. Mol. Biol. 36, 4.2.1-4.2.9.
333. Jacobson, A. (1987) Purification and fractionation of poly(A)+ RNA, Methods Enzymol., 152, 254-261.
334. Southern, E. M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis, J. Mol. Biol., 98, 503-517.
335. Brown, T., Mackey, K., and Du, T. (2004) Analysis of RNA by Northern and slot blot hybridization, Curr. Protoc. Mol. Biol. 67, 4.9.1-4.9.19.
336. Ogden, R. C. and Adams, D. A. (1987) Electrophoresis in agarose and acrylamide gels, Methods Enzymol., 152, 61-87.
337. Wahl, G. M., Meinkoth, J. L., and Kimmel, A. R. (1987) Northern and Southern blots, Methods Enzymol., 152, 572-581.
338. Bork, R. W., Muto, T., Beaune, P. H., Srivastava, P. K., Lloyd, R. S., and Guengerich, F. P. (1989) Characterization of mRNAspecies related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity, J. Biol. Chem., 264, 910-919.
339. Brown, T. (1999) Analysis of DNA sequences by blotting and hybridization, Curr. Protoc. Mol. Biol., 2.9.1-2.9.15.
340. Birnboim, H. C. and Doly, J. (1979) A rapid alkaline extraction procedure for screening recombinant plasmid DNA, Nucleic Acids Res., 7, 1513-1523.
341. Birnboim, H. C. (1983) A rapid alkaline extraction method for the isolation of plasmid DNA, Methods Enzymol., 100, 243-255.
342. Engelbrecht, J., Brent, R., and Kaderbhai, M. A. (1991) Minipreps of plasmid DNA, Curr. Protoc. Mol. Biol., 1.6.1-1.6.10.
343. Sambrook, J. and Russell, D. W. (2001) Molecular Cloning: A Laboratory Manual, 3rd edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
344. Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., and Erlich, H. (1986) Specific enzymatic amplification of DNAin vitro: The polymerase chain reaction, Cold Spring Harb. Symp. Quant. Biol. 51(Pt. 1), 263-273.
345. Kramer, M., and Coen, D. M. (2001) Enzymatic amplification of DNA by PCR: Standard procedures and optimization, Curr. Protoc. Mol. Biol., 15.11.11-15.11.14.
346. Kendew, J. (1994) The Encyclopedia of Molecular Biology, Blackwell Science, London, U.K.
347. Kunkel, T. A. (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection, Proc. Natl. Acad. Sci. USA, 82, 488-492.
348. Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Rapid and efficient site-specific mutagenesis without phenotypic selection, Methods Enzymol., 154, 367-382.
349. Vovis, G. F. and Lacks, S. (1977) Complementary action of restriction enzymes endo R-DpnI and endo R-DpnII on bacteriophage f1 DNA, J. Mol. Biol., 115, 525-538.
350. Wells, J. A., Vasser, M., and Powers, D. B. (1985) Cassette mutagenesis: An efficient method for generation of multiple mutations on defined sites, Gene, 34, 315-323.
351. Reidhaar-Olson, J. R. and Sauer, R. T. (1988) Combinatorial cassette mutagenesis as a probe of the informational content of protein sequences, Science, 241, 53-57.
352. Reidhaar-Olson, J. F., Bowie, J. U., Breyer, R. M., Hu, J. C., Knight, K. L., Lim, W. A., Mossing, M. C., Parsell, D. A., Shoemaker, K. R., and Sauer, R. T. (1991) Random mutagenesis of protein sequences using oligonucleotide cassettes, Methods Enzymol., 208, 564-586.
353. Martin, F. H., Castro, M. M., Aboul-ela, F., and Tinoco, I., Jr. (1985) Base pairing involving deoxyinosine: Implications for probe design, Nucleic Acids Res., 13, 8927-8938.
354. Evans-Storms, R. B. and Cidlowski, J. A. (1995) Regulation of apoptosis by steroid hormones, J. Steroid Biochem. Mol. Biol., 53, 1-8.
355. Simula, T. P., Glancey, M. J., and Wolf, C. R. (1993) Human glutathione S-transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: Studies with halogenated compounds, aromatic amines and aflatoxin B1, Carcinogenesis, 14, 1371-1376.
356. Yamazaki, Y., Fujita, K.-I., Nakayama, K., Suzuki, A., Nakamura, K., Yamazaki, H., and Kamataki, T. (2004) Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450reductase sensitive to various promutagens, Mutat. Res., 562, 151-162.
357. White, P. A. and Rasmussen, J. B. (1996) SOS chromotest results in a broader context: Empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency, Environ. Mol. Mutagen., 27, 270-305.
358. Ames, B. N., McCann, J., and Yamasaki, E. (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutat. Res., 31, 347-364.
359. Quillardet, P., Huisman, O., D’ari, R., and Hofnung, M. (1982) SOS chromotest, a direct assay of induction of an SOSfunction in Escherichia coli K-12 to measure genotoxicity, Proc. Natl. Acad. Sci. USA, 79, 5971-5975.
360. Quillardet, P. and Hofnung, M. (1985) The SOS Chromotest, a colorimetric bacterial assay for genotoxins: Procedures, Mutant. Res., 147, 65-78.
361. Valadez, J. G. and Guengerich, F. P. (2004) S-(2-Chloroethyl)glutathione-generated p53 mutation spectra are influenced by differential repair rates more than sites of initial DNA damage, J. Biol. Chem., 279, 13435-13446.
362. Liu, L., Hachey, D. L., Valadez, J. G., Williams, K. M., Guengerich, F. P., Loktionova, N. A., Kanugula, S., and Pegg, A. E. (2004) Characterization of a mutagenic DNA adduct formed from 1, 2-dibromoethane by O6-alkylguanine-DNAalkyltransferase, J. Biol. Chem., 279, 4250-4259.
363. Liu, L., Williams, K. M., Guengerich, F. P., and Pegg, A. E. (2004) O6-Alkylguanine-DNA alkyltransferase has opposing effects in modulating the genotoxicity of dibromomethane and bromomethyl acetate, Chem. Res. Toxicol., 17, 742-752.
364. Isin, E. M. and Guengerich, F. P. (2007) Complex reactions catalyzed by cytochrome P450 enzymes, Biochim. Biophys. Acta, 1770, 314-329.
365. Guengerich, F. P. and Isin, E. M. (2014) Unusual metabolic reactions and pathways, In Handbook of Metabolic Pathways of Xenobiotics, Vol. 1 (Prakash, C., Gau, L., Zhong, D., Aizawa, H., and Lee, P., eds.), John Wiley and Sons, New York, in press.